{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T06:27:21Z","timestamp":1787120841643,"version":"build-2736575974"},"reference-count":36,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T00:00:00Z","timestamp":1787097600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Hyper-IgE syndrome (HIES) is a rare primary immunodeficiency disorder distinguished by a triad of eczema, recurrent skin and pulmonary infections, and elevated serum IgE levels. The loss-of-function mutations in signal transducer and activator of transcription 3 (\n                      <jats:italic>STAT3<\/jats:italic>\n                      ) result in STAT3-HIES, which is considered the prototype form of HIES. Patients with STAT3-HIES are susceptible to\n                      <jats:italic>Staphylococcus aureus<\/jats:italic>\n                      and\n                      <jats:italic>Candida albicans<\/jats:italic>\n                      , while\n                      <jats:italic>Mycobacterium tuberculosis<\/jats:italic>\n                      infection is rare, usually accompanied by multiple non-immunologic features including skeletal and connective tissue abnormalities, and the increasing risk of lymphoma. Owing to the diverse clinical manifestations of this disease and the lack of specific symptoms in its early stage, delayed diagnosis often occurs.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case presentation<\/jats:title>\n                    <jats:p>This report describes two cases of children with STAT3-HIES. One case was a 3-year-old child who presented with intestinal intussusception as the initial symptom and was considered to have probable intestinal tuberculosis and accompanied by miliary pulmonary tuberculosis, and tuberculosis was cured after one year of anti-infection treatment, HIES combined with intestinal tuberculosis presenting with intussusception as the clinical manifestation has never been reported. Second case was a 16-year-old child who was diagnosed with anaplastic lymphoma kinase-negative anaplastic large cell lymphoma because of swollen lymph nodes in the neck at the age of 10, he underwent allogeneic hematopoietic stem cell transplantation when he was 16 years old, unfortunately he died of lung infection after three months.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The cases described in this article enhance our understanding of the manifestations, treatment and prognosis of this syndrome, highlighting the hazards of active tuberculosis and lymphoma in patients with HIES, as well as the importance of timely diagnosis, individualized treatment and follow-up.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fped.2026.1872306","type":"journal-article","created":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T05:45:23Z","timestamp":1787118323000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Case Report: STAT3 hyper-IgE syndrome in children: two cases report with uncommon complications of tuberculosis and lymphoma"],"prefix":"10.3389","volume":"14","author":[{"given":"Xiaobei","family":"Cao","sequence":"first","affiliation":[{"name":"Department of Pediatric Respiratory Medicine, Tianjin Children's Hospital (Children's Hospital, Tianjin University), Tianjin Key Laboratory of Birth Defects for Prevention and Treatment","place":["Tianjin, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Pediatric Respiratory Medicine, Tianjin Children's Hospital (Children's Hospital, Tianjin University), Tianjin Key Laboratory of Birth Defects for Prevention and Treatment","place":["Tianjin, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongsheng","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Pediatric Respiratory Medicine, Tianjin Children's Hospital (Children's Hospital, Tianjin University), Tianjin Key Laboratory of Birth Defects for Prevention and Treatment","place":["Tianjin, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,8,19]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1111\/imcb.12209","article-title":"Hyper-IgE syndromes: clinical and molecular characteristics","volume":"97","author":"Al-Shaikhly","year":"2019","journal-title":"Immunol Cell Biol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1007\/s10875-021-01051-1","article-title":"STAT3 hyper-IgE syndrome: an update and unanswered questions","volume":"41","author":"Tsilifis","year":"2021","journal-title":"J Clin Immunol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.3390\/life14101329","article-title":"Pathophysiology of congenital high production of IgE and its consequences: a narrative review uncovering a neglected setting of disorders","volume":"14","author":"Galletta","year":"2024","journal-title":"Life (Basel)"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1516068","DOI":"10.3389\/fimmu.2025.1516068","article-title":"The genetics of hyper IgE syndromes","volume":"16","author":"AlYafie","year":"2025","journal-title":"Front Immunol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.1007\/s10875-022-01352-z","article-title":"The 2022 update of IUIS phenotypical classification for human inborn errors of immunity","volume":"42","author":"Bousfiha","year":"2022","journal-title":"J Clin Immunol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1056\/NEJMra1202117","article-title":"JAKs and STATs in immunity, immunodeficiency, and cancer","volume":"368","author":"O\u2019Shea","year":"2013","journal-title":"N Engl J Med"},{"key":"B7","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1038\/ni.3691","article-title":"Mechanisms and consequences of JAK-STAT signaling in the immune system","volume":"18","author":"Villarino","year":"2017","journal-title":"Nat Immunol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1038\/nature06764","article-title":"Impaired T(H)17 cell differentiation in subjects with autosomal dominant hyper-IgE syndrome","volume":"452","author":"Milner","year":"2008","journal-title":"Nature"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.3390\/genes16121445","article-title":"TYK2 deficiency presenting as refractory disseminated BCG\/tuberculosis infection in a Kazakh child: a case report with genetic confirmation","volume":"16","author":"Sikhayeva","year":"2025","journal-title":"Genes (Basel)"},{"key":"B10","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1016\/j.jaip.2017.06.041","article-title":"Autosomal dominant hyper-IgE syndrome in the USIDNET registry","volume":"6","author":"Gernez","year":"2018","journal-title":"J Allergy Clin Immunol Pract"},{"key":"B11","doi-asserted-by":"publisher","first-page":"3056","DOI":"10.1111\/trf.15020","article-title":"Humoral immunodeficiencies: conferred risk of infections and benefits of immunoglobulin replacement therapy","author":"Gernez","year":"2018","journal-title":"Transfusion"},{"key":"B12","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/j.ccm.2016.04.016","article-title":"Hyper-IgE syndromes and the lung","volume":"37","author":"Freeman","year":"2016","journal-title":"Clin Chest Med"},{"key":"B13","doi-asserted-by":"publisher","first-page":"4835","DOI":"10.1007\/s10238-023-01228-5","article-title":"A systematic review regarding the prevalence of malignancy in patients with the hyper-IgE syndrome","volume":"23","author":"Mohammadi","year":"2023","journal-title":"Clin Exp Med"},{"key":"B14","doi-asserted-by":"publisher","first-page":"e85872","DOI":"10.7759\/cureus.85872","article-title":"Overview of Mendelian susceptibility to mycobacterial diseases (MSMD)","volume":"17","author":"Raghuraman","year":"2025","journal-title":"Cureus"},{"key":"B15","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1111\/j.1328-0867.2004.01845.x","article-title":"Tuberculous brain abscess in a patient with hyper IgE syndrome","volume":"46","author":"Metin","year":"2004","journal-title":"Pediatr Int"},{"key":"B16","doi-asserted-by":"publisher","first-page":"22","DOI":"10.5897\/JCIIR11.022","article-title":"Job\u2019s syndrome: a rare presentation of pulmonary Koch\u2019s with multiple splenic abscess","volume":"4","author":"Mahla","year":"2012","journal-title":"J Clin Immunol Immunopathol Res"},{"key":"B17","doi-asserted-by":"publisher","first-page":"95","DOI":"10.4103\/2319-7250.122179","article-title":"Tuberculous osteomyelitis in job syndrome","volume":"14","author":"Singhal","year":"2013","journal-title":"Indian J Paediatr Dermatol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"626593","DOI":"10.3389\/fimmu.2021.626593","article-title":"Clinical profile of hyper-IgE syndrome in India","volume":"12","author":"Saikia","year":"2021","journal-title":"Front Immunol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1186\/s13023-025-03749-6","article-title":"Pulmonary features and stage of disease in adult patients with hyper-IgE syndrome: a single-centre clinical study and literature review","volume":"20","author":"Xie","year":"2025","journal-title":"Orphanet J Rare Dis"},{"key":"B20","doi-asserted-by":"publisher","first-page":"e23435","DOI":"10.4161\/jkst.23435","article-title":"STAT3 and the hyper-IgE syndrome: clinical presentation, genetic origin, pathogenesis, novel findings and remaining uncertainties","volume":"2","author":"Mogensen","year":"2013","journal-title":"JAKSTAT"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1332817","DOI":"10.3389\/fimmu.2024.1332817","article-title":"Unraveling the unphosphorylated STAT3-unphosphorylated NF-\u03baB pathway in loss of function STAT3 hyper-IgE syndrome","volume":"15","author":"Karim","year":"2024","journal-title":"Front Immunol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1016\/j.jaci.2022.12.821","article-title":"STAT3 mutation-associated airway epithelial defects in job syndrome","volume":"152","author":"Zhang","year":"2023","journal-title":"J Allergy Clin Immunol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"14831","DOI":"10.3748\/wjg.v20.i40.14831","article-title":"Abdominal tuberculosis of the gastrointestinal tract: revisited","volume":"20","author":"Debi","year":"2014","journal-title":"World J Gastroenterol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"206","DOI":"10.5946\/ce.2016.076","article-title":"Endoscopic treatment of intussusception due to intestinal tuberculosis","volume":"50","author":"Kim","year":"2017","journal-title":"Clin Endosc"},{"key":"B25","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s12664-023-01343-x","article-title":"Evidence-based approach to diagnosis and management of abdominal tuberculosis","volume":"42","author":"Jha","year":"2023","journal-title":"Indian J Gastroenterol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1182\/blood-2007-04-087734","article-title":"Constitutively activated STAT3 promotes cell proliferation and survival in the activated B-cell subtype of diffuse large B-cell lymphomas","volume":"111","author":"Ding","year":"2008","journal-title":"Blood"},{"key":"B27","doi-asserted-by":"publisher","first-page":"865","DOI":"10.3760\/cma.j.issn.0253-2727.2020.10.014","article-title":"Diffuse large B-cell lymphoma in a patient with hyper-IgE syndrome: a case report and literature review","volume":"41","author":"Zhang","year":"2020","journal-title":"Zhonghua Xue Ye Xue Za Zhi (Chinese)"},{"key":"B28","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1097\/MD.0b013e31825f95b9","article-title":"Autosomal dominant STAT3 deficiency and hyper-IgE syndrome: molecular, cellular, and clinical features from a French national survey","volume":"91","author":"Chandesris","year":"2012","journal-title":"Medicine (Baltimore)"},{"key":"B29","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1111\/j.1365-4632.2003.01829.x","article-title":"Extensive xanthelasma associated with anaplastic large cell lymphoma and hyperimmunoglobulin E syndrome","volume":"42","author":"Lee","year":"2003","journal-title":"Int J Dermatol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.immuni.2011.12.019","article-title":"Stat3 and Gfi-1 transcription factors control Th17 cell immunosuppressive activity via the regulation of ectonucleotidase expression","volume":"36","author":"Chalmin","year":"2012","journal-title":"Immunity"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1850359","DOI":"10.3389\/fimmu.2026.1850359","article-title":"STAT3 At the tumor-immune interface: mechanisms of immune escape and therapeutic opportunities","volume":"17","author":"Cheng","year":"2026","journal-title":"Front Immunol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"488","DOI":"10.3390\/cells14070488","article-title":"The role of inflammation in cancer: mechanisms of tumor initiation, progression, and metastasis","volume":"14","author":"Nishida","year":"2025","journal-title":"Cells"},{"key":"B33","doi-asserted-by":"publisher","first-page":"19","DOI":"10.3390\/cancers12010019","article-title":"STAT3 activation and oncogenesis in lymphoma","volume":"12","author":"Zhu","year":"2020","journal-title":"Cancers (Basel)"},{"key":"B34","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1016\/j.jaip.2018.10.035","article-title":"Hematopoietic stem cell transplantation as treatment for patients with DOCK8 deficiency","volume":"7","author":"Aydin","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"key":"B35","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1007\/s10875-016-0278-1","article-title":"The potential and limits of hematopoietic stem cell transplantation for the treatment of autosomal dominant hyper-IgE syndrome","volume":"36","author":"Yanagimachi","year":"2016","journal-title":"J Clin Immunol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"4126","DOI":"10.1182\/bloodadvances.2025016158","article-title":"Allogeneic hematopoietic stem cell transplantation for STAT3 hyper-IgE syndrome: a worldwide study","volume":"9","author":"Tsilifis","year":"2025","journal-title":"Blood Adv"}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2026.1872306\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T05:45:29Z","timestamp":1787118329000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2026.1872306\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,19]]},"references-count":36,"alternative-id":["10.3389\/fped.2026.1872306"],"URL":"https:\/\/doi.org\/10.3389\/fped.2026.1872306","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,19]]},"article-number":"1872306"}}